Drug Profile
Research programme: chronic hepatitis B therapeutics - Fresh Tracks Therapeutics
Alternative Names: VR CHB01Latest Information Update: 26 Sep 2023
Price :
$50
*
At a glance
- Originator Vical
- Developer Fresh Tracks Therapeutics
- Class Antivirals
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis B